Dolby Laboratories, Inc. income statement DLB

In fiscal 2025, which ended Sep 26, 2025, Dolby Laboratories, Inc. reported revenue of $1.3 billion, up 5.9% from the year before. Net income was $255.0 million, a profit margin of 18.9%. Operating income came to $265.0 million, an operating margin of 19.6%. Diluted earnings per share were $2.62. Over the twelve months ended Jun 26, 2026, revenue was $1.4 billion and net income was $226.2 million. Across the 10 fiscal years shown, revenue grew from $1.0 billion in fiscal 2016 to $1.3 billion in fiscal 2025, about 3.1% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 26, 2026
FY 2025
Sep 26, 2025
FY 2024
Sep 27, 2024
FY 2023
Sep 29, 2023
FY 2022
Sep 30, 2022
FY 2021
Sep 24, 2021
FY 2020
Sep 25, 2020
FY 2019
Sep 27, 2019
FY 2018
Sep 28, 2018
FY 2017
Sep 29, 2017
FY 2016
Sep 30, 2016
Revenue
1,354
+0.6%
1,349
+5.9%
1,274
-2.0%
1,300
+3.7%
1,254
-2.1%
1,281
+10.3%
1,162
-6.4%
1,242
+17.7%
1,055
-2.4%
1,080
+5.3%
1,026
+5.7%
Cost of revenue
168
+8.5%
160
+14.0%
140
-7.9%
153
+7.9%
141
+8.7%
130
-11.2%
146
-8.9%
161
+26.1%
128
+7.6%
119
+8.8%
109
+14.9%
Gross profit
1,187
-0.5%
1,189
+4.9%
1,133
-1.2%
1,147
+3.1%
1,112
-3.4%
1,151
+13.4%
1,015
-6.1%
1,081
+16.6%
927
-3.6%
962
+4.9%
917
+4.7%
Research and development
266
+1.1%
262
-0.7%
264
-2.9%
272
+4.0%
261
+3.0%
254
+6.1%
239
+0.5%
238
+0.5%
237
+1.5%
233
+6.2%
220
+9.1%
Selling, general and administrative
659
+2.9%
647
+7.0%
605
-1.3%
613
-3.3%
634
+13.9%
557
+0.2%
556
+1.2%
549
+8.3%
507
+8.3%
468
+0.9%
464
+0.6%
Restructuring and impairment
23
+199.6%
15
+135.1%
6
-86.4%
47
+343.0%
11
+3.7%
10
+462.3%
2
-95.0%
37
+8296.9%
-0
-103.5%
13
+942.7%
1
+1641.3%
Operating expenses
947
+4.0%
924
+5.6%
875
-6.1%
931
+2.8%
906
—
797
-3.3%
824
+10.8%
744
+4.1%
715
+4.3%
685
+3.4%
Operating income
239
-15.1%
265
+2.6%
258
+19.7%
216
+4.4%
207
-40.0%
344
+57.4%
219
-14.9%
257
+40.1%
184
-25.7%
247
+6.6%
232
+8.7%
Other income (expense)
38
-5.6%
39
-28.9%
54
+57.9%
34
+295.4%
9
-14.3%
10
-51.7%
21
-16.9%
25
+96.1%
13
+60.6%
8
+95.0%
4
-87.4%
Pretax income
277
-13.9%
303
-2.9%
312
+25.0%
250
+16.2%
215
-39.3%
355
+47.9%
240
-15.1%
282
+43.8%
196
-23.0%
255
+8.2%
236
-4.0%
Income tax
49
-12.7%
47
-2.4%
48
-0.5%
48
+54.3%
31
-14.5%
37
+353.2%
8
-69.8%
27
-82.6%
154
+220.7%
48
-3.0%
50
-20.8%
Net income
226
-14.4%
255
-2.6%
262
+30.5%
201
+9.0%
184
-40.7%
310
+34.1%
231
-9.3%
255
+511.2%
42
-79.8%
206
+11.1%
186
+2.5%
Basic EPS
2.38
-13.8%
2.66
-2.9%
2.74
+30.5%
2.10
+14.1%
1.84
-40.1%
3.07
+33.5%
2.30
-8.4%
2.51
+527.5%
0.40
-80.3%
2.03
+9.7%
1.85
+4.5%
Diluted EPS
2.35
-13.3%
2.62
-2.6%
2.69
+31.2%
2.05
+13.3%
1.81
-39.1%
2.97
+32.0%
2.25
-7.8%
2.44
+525.6%
0.39
-80.5%
2.00
+10.5%
1.81
+3.4%
Weighted average shares, basic
95
-0.7%
96
+0.3%
96
-0.2%
96
-4.2%
100
-1.2%
101
+0.6%
101
-1.0%
102
-1.7%
103
+1.6%
102
+1.1%
101
-1.6%
Weighted average shares, diluted
96
-1.2%
97
+0.2%
97
-0.4%
98
-4.2%
102
-2.5%
105
+1.6%
103
-1.6%
105
-2.2%
107
+3.6%
103
+0.8%
102
-1.4%
Other measures
Depreciation and amortization
93
+6.5%
88
+16.2%
76
-8.5%
83
-6.7%
88
-7.7%
96
+5.5%
91
+6.8%
85
+4.7%
81
-3.6%
84
-1.0%
85
+23.2%
EBITDA
332
-10.0%
353
+5.7%
334
+11.9%
298
+1.1%
295
-33.0%
440
+42.2%
310
-9.5%
342
+29.2%
265
-20.1%
331
+4.6%
317
+12.2%
Interest coverage
—
—
—
—
524.38x
718.98x
1,176.03x
1,512.22x
926.79x
1,945.93x
1,854.36x
Margins
Gross margin
87.61%
88.13%
88.97%
88.26%
88.73%
89.85%
87.39%
87.04%
87.90%
89.03%
89.38%
Operating margin
17.65%
19.64%
20.28%
16.60%
16.48%
26.88%
18.83%
20.70%
17.40%
22.88%
22.60%
Pretax margin
20.44%
22.49%
24.53%
19.24%
17.17%
27.67%
20.63%
22.74%
18.62%
23.62%
23.00%
Profit margin
16.70%
18.90%
20.56%
15.44%
14.68%
24.21%
19.91%
20.55%
3.96%
19.12%
18.12%
EBITDA margin
24.51%
26.15%
26.21%
22.95%
23.53%
34.36%
26.65%
27.56%
25.11%
30.68%
30.90%
Effective tax rate
17.63%
15.48%
15.41%
19.36%
14.58%
10.35%
3.38%
9.49%
78.46%
18.83%
20.98%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Patent Owners & Lessors (SIC 6794)
Listed as
DLB (NYSE)
Fiscal year ends
September 27
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1308547

Other Patent Owners & Lessors companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.